Atrial Fibrillation Patients Treated With Catheter Ablation

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Feb 23, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the use of a treatment called radiofrequency ablation for patients with atrial fibrillation, a condition where the heart beats irregularly. The goal is to see how effective this procedure is in helping patients manage their symptoms and improve their heart health. The trial is currently looking for participants who are between 18 and 80 years old and have certain types of atrial fibrillation. To qualify, potential participants must have a specific heart size and meet certain medical criteria determined by heart specialists.

If you join the trial, you will receive the ablation treatment, which involves using heat to destroy small areas of heart tissue that are causing the irregular heartbeat. Participants will be closely monitored during and after the procedure to assess its effectiveness and any side effects. It's important to note that individuals with certain conditions, such as blood clots in the heart or previous heart procedures for atrial fibrillation, cannot participate. Overall, this trial aims to provide valuable insights into how this treatment can help those suffering from atrial fibrillation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Non-valvular atrial fibrillation, including paroxysmal atrial fibrillation and persistent atrial fibrillation
• • 18-80 years old
• • The anteroposterior diameter of the left atrium is less than 50mm via TTE
• • Patient meets the intervention criteria for bilateral pulmonary vein isolation after evaluation by electrophysiological specialists
• • Patient consents to ablation treatment
• Exclusion Criteria:
• • Intra-atrial thrombus detected by TEE
• • Hyperthyroidism
• • Previous radiofrequency ablation for atrial fibrillation